Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer.

Trial Profile

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Apr 2012

At a glance

  • Drugs Fadrozole; Letrozole
  • Indications Advanced breast cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Apr 2012 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
    • 17 Apr 2012 Actual patient number is 17 according to ClinicalTrials.gov.
    • 07 Sep 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top